Literature DB >> 19667266

Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation.

Ali G Saad1, Edwin P Alyea, Patrick Y Wen, Umberto Degirolami, Santosh Kesari.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19667266     DOI： 10.1200/JCO.2009.21.7919

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  19 in total

1.  CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis.

Authors:  Saravanan Kaliyaperumal; Benjamin Watkins; Prachi Sharma; Scott Furlan; Swetha Ramakrishnan; Cynthia Giver; Anapatricia Garcia; Cynthia Courtney; Heather Knight; Elizabeth Strobert; Eric Elder; Timothy Crenshaw; Bruce R Blazar; Edmund K Waller; Susan Westmoreland; Leslie S Kean
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

2.  Hemichoreo-hemibalism as a Manifestation of Central Nervous System Chronic Graft-versus-Host Disease.

Authors:  Alejandro Enriquez-Marulanda; Melibea Sierra-Ruiz; Francisco Javier Jaramillo; Luis Alberto Escobar; Ana María Granados; Lisa Ximena Rodríguez-Rojas; Andrew J Lees; Jorge Luis Orozco
Journal:  Mov Disord Clin Pract       Date:  2017-05-25

3.  Bilateral Inflammatory Optic Neuropathy Related to Graft versus Host Disease Following Allogeneic Bone Marrow Transplantation for Hodgkin Disease.

Authors:  I Moesen; D P Kidd
Journal:  Neuroophthalmology       Date:  2014-07-22

4.  Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia.

Authors:  Nimitha R Mathew; Janaki M Vinnakota; Petya Apostolova; Daniel Erny; Shaimaa Hamarsheh; Geoffroy Andrieux; Jung-Seok Kim; Kathrin Hanke; Tobias Goldmann; Louise Chappell-Maor; Nadia El-Khawanky; Gabriele Ihorst; Dominik Schmidt; Justus Duyster; Jürgen Finke; Thomas Blank; Melanie Boerries; Bruce R Blazar; Steffen Jung; Marco Prinz; Robert Zeiser
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

5.  The central nervous system is a target of acute graft versus host disease in mice.

Authors:  Steffen Hartrampf; Jarrod A Dudakov; Linda K Johnson; Odette M Smith; Jennifer Tsai; Natalie V Singer; Mallory L West; Alan M Hanash; Michael H Albert; Bingfang Liu; Miklos Toth; Marcel R M van den Brink
Journal:  Blood       Date:  2013-01-08       Impact factor: 22.113

6.  Successful treatment of meningeal graft-versus-host disease in a haematopoietic stem cell transplant recipient.

Authors:  Victoria Pechey; John Parratt; Linh Vo; William Stevenson
Journal:  Int J Hematol       Date:  2014-11-22       Impact factor: 2.490

7.  Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD.

Authors:  Ludovic Belle; Vivian Zhou; Kara L Stuhr; Margaret Beatka; Emily M Siebers; Jennifer M Knight; Michael W Lawlor; Casey Weaver; Misato Hashizume; Cecilia J Hillard; William R Drobyski
Journal:  JCI Insight       Date:  2017-07-20

8.  Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.

Authors:  Anna Maria Delios; Marc Rosenblum; Ann A Jakubowski; Lisa M DeAngelis
Journal:  J Neurooncol       Date:  2012-08-23       Impact factor: 4.130

9.  Successful treatment with fingolimod of graft-versus-host disease of the central nervous system.

Authors:  Jordan Gauthier; Patrick Vermersch; Paul Chauvet; Pauline Varlet; Valérie Coiteux; Leonardo Magro; Ibrahim Yakoub-Agha
Journal:  Blood Adv       Date:  2018-01-02

Review 10.  Epileptic Seizures After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Zhuo Wang; Munan Zhao; Sujun Gao
Journal:  Front Neurol       Date:  2021-07-16       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.